2011
DOI: 10.1016/j.vaccine.2010.10.040
|View full text |Cite
|
Sign up to set email alerts
|

MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
64
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(69 citation statements)
references
References 55 publications
5
64
0
Order By: Relevance
“…Generally, Th1 cells secrete IgG2a antibody, and Th2 cells secrete IgG1 antibody, and the ratio of IgG2a/IgG1 directs a Th1-biased immune response. 44 In our study, OVA-PHYP elicited the highest IgG2a/IgG1 ratio, as illustrated in Figure 5B, which indicated an intensive bias toward Th1 compared with the empty PLA nanospheres or drug alone. Furthermore, the cellular immune responses by splenocytes and DCs from mice being inoculated were also investigated.…”
supporting
confidence: 58%
“…Generally, Th1 cells secrete IgG2a antibody, and Th2 cells secrete IgG1 antibody, and the ratio of IgG2a/IgG1 directs a Th1-biased immune response. 44 In our study, OVA-PHYP elicited the highest IgG2a/IgG1 ratio, as illustrated in Figure 5B, which indicated an intensive bias toward Th1 compared with the empty PLA nanospheres or drug alone. Furthermore, the cellular immune responses by splenocytes and DCs from mice being inoculated were also investigated.…”
supporting
confidence: 58%
“…However, interest in the adjuvant potential of P. acnes-derived preparations continues. MIS416 is a microparticle immunostimulant comprising P. acnes whole-cells extracted with alcohols and guanidine to give a minimal cell wall skeleton rich in immunostimulatory crosslinked muramyl dipeptide repeats and native bacterial DNA fragments, each of which have known adjuvant activity [95]. There is also continued interest in the development of vaccines based on various P. acnes components, including a surface sialidase [96,97] and a secreted CAMP factor [98].…”
Section: Vaccinesmentioning
confidence: 99%
“…One recent report favoured MDP as part of an experimental proteoliposome-based vaccine formulation against Candida species, since effective immune responses were induced in mice without toxic effects (Mašek et al, 2011). Similarly, administration of biodegradable microparticles comprising MDP with bacterial DNA from Propionibacterium acnes (MIS416) resulted in a nontoxic Th1 cellular adjuvant with desirable immunostimulatory properties in mice and rabbits (Girvan et al, 2011). We have previously demonstrated that microglia respond to TLR1/2, 3, 4 and 9 agonists by increasing their capacity to phagocytose and kill ingested E. coli strains (Ribes et al, 2009).…”
Section: Tablementioning
confidence: 99%